• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉病毒糖蛋白(GP)和截短型GP异构体DNA疫苗诱导的免疫反应特征及对小鼠致死性埃博拉病毒攻击的保护作用

Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.

作者信息

Li Wenfang, Ye Ling, Carrion Ricardo, Mohan Gopi S, Nunneley Jerritt, Staples Hilary, Ticer Anysha, Patterson Jean L, Compans Richard W, Yang Chinglai

机构信息

Department of Microbiology and Immunology Emory Vaccine Center, Emory University, Atlanta, Georgia.

Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.

出版信息

J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S398-403. doi: 10.1093/infdis/jiv186. Epub 2015 Apr 14.

DOI:10.1093/infdis/jiv186
PMID:25877553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4564543/
Abstract

In addition to its surface glycoprotein (GP), Ebola virus directs the production of large quantities of a truncated glycoprotein isoform (sGP) that is secreted into the extracellular space. We recently reported that sGP actively diverts host antibody responses against the epitopes that it shares with GP and thereby allows itself to absorb anti-GP antibodies, a phenomenon we termed "antigenic subversion." To investigate the effect of antigenic subversion by sGP on protection against virus infection, we compared immune responses induced by different prime-boost immunization regimens with GP and sGP DNA vaccines in mice and their efficacy against lethal Ebola virus challenge. Similar levels of anti-GP antibodies were induced by 2 immunizations with sGP and GP DNA vaccines. However, 2 immunizations with GP but not sGP DNA vaccine fully protected mice from lethal challenge. Boosting with sGP or GP DNA vaccine in mice that had been primed by GP or sGP DNA vaccine augmented the levels of anti-GP antibody responses and further improved protective efficacy against Ebola virus infection. These results show that both the quality and the levels of anti-GP antibody responses affect the efficacy of protection against Ebola virus infection.

摘要

除了其表面糖蛋白(GP)外,埃博拉病毒还指导产生大量截短的糖蛋白异构体(sGP),这些异构体被分泌到细胞外空间。我们最近报道,sGP会主动转移宿主针对其与GP共有的表位的抗体反应,从而使自身能够吸收抗GP抗体,我们将这一现象称为“抗原颠覆”。为了研究sGP的抗原颠覆对预防病毒感染的影响,我们比较了在小鼠中用GP和sGP DNA疫苗进行不同的初免-加强免疫方案诱导的免疫反应及其对致死性埃博拉病毒攻击的效力。用sGP和GP DNA疫苗进行两次免疫诱导的抗GP抗体水平相似。然而,用GP而非sGP DNA疫苗进行两次免疫可使小鼠完全免受致死性攻击。在已用GP或sGP DNA疫苗进行初免的小鼠中,用sGP或GP DNA疫苗进行加强免疫可提高抗GP抗体反应水平,并进一步提高对埃博拉病毒感染的保护效力。这些结果表明,抗GP抗体反应的质量和水平均会影响对埃博拉病毒感染的保护效力。

相似文献

1
Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.埃博拉病毒糖蛋白(GP)和截短型GP异构体DNA疫苗诱导的免疫反应特征及对小鼠致死性埃博拉病毒攻击的保护作用
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S398-403. doi: 10.1093/infdis/jiv186. Epub 2015 Apr 14.
2
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.抗原颠覆:埃博拉病毒逃避宿主免疫的新机制。
PLoS Pathog. 2012;8(12):e1003065. doi: 10.1371/journal.ppat.1003065. Epub 2012 Dec 13.
3
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.基于痘病毒的埃博拉病毒表达 GP 和 VP40 蛋白疫苗候选物的免疫原性和疗效的差异。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.
4
Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.在一项短期保护研究中针对小鼠适应型埃博拉病毒的初免-加强免疫接种策略的优化
J Infect Dis. 2015 Oct 1;212 Suppl 2:S389-97. doi: 10.1093/infdis/jiv175. Epub 2015 Jun 2.
5
Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.经皮微针贴片接种含佐剂的埃博拉病毒可溶性糖蛋白亚单位疫苗可保护小鼠免受致死性埃博拉病毒攻击。
J Infect Dis. 2018 Nov 22;218(suppl_5):S545-S552. doi: 10.1093/infdis/jiy267.
6
Protection against lethal challenge by Ebola virus-like particles produced in insect cells.昆虫细胞中产生的埃博拉病毒样颗粒对致死性攻击的保护作用。
Virology. 2009 Jan 5;383(1):12-21. doi: 10.1016/j.virol.2008.09.020. Epub 2008 Nov 4.
7
Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.微针贴片皮内免疫埃博拉病毒 GP 亚单位疫苗可保护小鼠免受致死性 EBOV 挑战。
Sci Rep. 2018 Jul 25;8(1):11193. doi: 10.1038/s41598-018-29135-w.
8
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.埃博拉病毒 GP 和 sGP 与治疗性抗体复合物的结构。
Nat Microbiol. 2016 Aug 8;1(9):16128. doi: 10.1038/nmicrobiol.2016.128.
9
Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.基因工程改造的狂犬病病毒载体埃博拉病毒病疫苗在小鼠和犬中安全,并能诱导有效的免疫应答。
Antiviral Res. 2017 Oct;146:36-44. doi: 10.1016/j.antiviral.2017.08.011. Epub 2017 Aug 16.
10
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.通过对转染色体牛进行DNA疫苗接种产生的人源多克隆抗体为小鼠提供暴露后针对致死性扎伊尔和苏丹埃博拉病毒的保护。
PLoS One. 2015 Sep 30;10(9):e0137786. doi: 10.1371/journal.pone.0137786. eCollection 2015.

引用本文的文献

1
Intradermal Immunization of EBOV VLPs in Guinea Pigs Induces Broader Antibody Responses Against GP Than Intramuscular Injection.在豚鼠中对埃博拉病毒样颗粒进行皮内免疫比肌肉注射诱导出更广泛的针对糖蛋白(GP)的抗体反应。
Front Microbiol. 2020 Feb 27;11:304. doi: 10.3389/fmicb.2020.00304. eCollection 2020.
2
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.埃博拉病毒和马尔堡病毒疫苗:最新进展和有前途的候选疫苗。
Hum Vaccin Immunother. 2019;15(10):2359-2377. doi: 10.1080/21645515.2019.1651140. Epub 2019 Oct 7.
3
Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections.影响针对病毒感染的Fc介导免疫反应的研究不足的因素
Vaccines (Basel). 2019 Aug 30;7(3):103. doi: 10.3390/vaccines7030103.
4
Porcine IL-12 plasmid as an adjuvant improves the cellular and humoral immune responses of DNA vaccine targeting transmissible gastroenteritis virus spike gene in a mouse model.猪白细胞介素-12质粒作为佐剂可增强DNA疫苗针对小鼠模型中传染性胃肠炎病毒刺突基因的细胞免疫和体液免疫反应。
J Vet Med Sci. 2019 Oct 18;81(10):1438-1444. doi: 10.1292/jvms.18-0682. Epub 2019 Sep 2.
5
Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.微针贴片皮内免疫埃博拉病毒 GP 亚单位疫苗可保护小鼠免受致死性 EBOV 挑战。
Sci Rep. 2018 Jul 25;8(1):11193. doi: 10.1038/s41598-018-29135-w.
6
Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.经皮微针贴片接种含佐剂的埃博拉病毒可溶性糖蛋白亚单位疫苗可保护小鼠免受致死性埃博拉病毒攻击。
J Infect Dis. 2018 Nov 22;218(suppl_5):S545-S552. doi: 10.1093/infdis/jiy267.
7
An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.一种基于腺病毒血清型 2 的埃博拉病毒疫苗在小鼠和恒河猴中产生了强烈的抗体和细胞介导的免疫应答。
Emerg Microbes Infect. 2018 Jun 6;7(1):101. doi: 10.1038/s41426-018-0102-5.
8
Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.豚鼠中增殖受限的水疱性口炎病毒编码埃博拉病毒糖蛋白的免疫原性。
J Gen Virol. 2018 Jul;99(7):866-879. doi: 10.1099/jgv.0.001085. Epub 2018 Jun 5.
9
Expression of Clonorchis sinensis GIIIsPLA protein in baculovirus-infected insect cells and its overexpression facilitating epithelial-mesenchymal transition in Huh7 cells via AKT pathway.华支睾吸虫GIIIsPLA蛋白在杆状病毒感染的昆虫细胞中的表达及其过表达通过AKT途径促进Huh7细胞上皮-间质转化。
Parasitol Res. 2017 Apr;116(4):1307-1316. doi: 10.1007/s00436-017-5409-y. Epub 2017 Feb 20.
10
Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.利用埃博拉糖蛋白特异性马 IgG 成功对感染埃博拉病毒的非人类灵长类动物进行暴露后预防。
Sci Rep. 2017 Feb 3;7:41537. doi: 10.1038/srep41537.

本文引用的文献

1
Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells.深度测序鉴定了感染细胞中埃博拉病毒和马尔堡病毒RNA的非规范编辑。
mBio. 2014 Nov 4;5(6):e02011. doi: 10.1128/mBio.02011-14.
2
Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.用狂犬病病毒为基础的双价疫苗免疫的非人灵长类动物中的抗体质量和对致命埃博拉病毒挑战的保护。
PLoS Pathog. 2013;9(5):e1003389. doi: 10.1371/journal.ppat.1003389. Epub 2013 May 30.
3
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.委内瑞拉马脑炎病毒复制子颗粒疫苗可保护非人灵长类动物免受埃博拉病毒的肌肉内和呼吸道挑战。
J Virol. 2013 May;87(9):4952-64. doi: 10.1128/JVI.03361-12. Epub 2013 Feb 13.
4
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.抗体对于 rVSV/ZEBOV-GP 介导的非人类灵长类动物抵抗致死性埃博拉病毒攻击的保护是必要的。
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1893-8. doi: 10.1073/pnas.1209591110. Epub 2013 Jan 14.
5
Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.抗原颠覆:埃博拉病毒逃避宿主免疫的新机制。
PLoS Pathog. 2012;8(12):e1003065. doi: 10.1371/journal.ppat.1003065. Epub 2012 Dec 13.
6
Transmission of Ebola virus from pigs to non-human primates.埃博拉病毒从猪传播给非人类灵长类动物。
Sci Rep. 2012;2:811. doi: 10.1038/srep00811. Epub 2012 Nov 15.
7
Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates.免疫参数与啮齿动物和非人类灵长类动物对埃博拉病毒感染的保护作用相关。
Sci Transl Med. 2012 Oct 31;4(158):158ra146. doi: 10.1126/scitranslmed.3004582.
8
Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.用单克隆抗体成功治疗感染埃博拉病毒的食蟹猴。
Sci Transl Med. 2012 Jun 13;4(138):138ra81. doi: 10.1126/scitranslmed.3003876.
9
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.接触后抗体预防可保护非人灵长类动物免受丝状病毒病的侵害。
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5034-9. doi: 10.1073/pnas.1200409109. Epub 2012 Mar 12.
10
Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.基因组 RNA 编辑及其对埃博拉病毒在细胞培养中连续传代和感染豚鼠过程中适应性的影响。
J Infect Dis. 2011 Nov;204 Suppl 3:S941-6. doi: 10.1093/infdis/jir321.